Login / Signup

Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability.

Luis Correia PinheiroXavier Kurz
Published in: Pharmacoepidemiology and drug safety (2022)
Keyphrases
  • artificial intelligence
  • machine learning
  • big data
  • adverse drug
  • deep learning
  • transcription factor
  • drug induced